| (USD) | Jun 2026 | Y/Y change |
|---|---|---|
| Revenue | 238.95M | — |
| Operating expense | — | — |
| Net income | 80.08M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, VIR returned +113.5% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | +62.2% |
| 1 year | +113.5% |
| 5 years | -81.0% |
| All-time high | $64.54 (Jan 2021) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in VIR would be worth today ›No. Vir Biotechnology, Inc. has not paid a dividend in the past 12 months.
Vir Biotechnology, Inc. stock trades on NASDAQ under the ticker symbol VIR.
Vir Biotechnology, Inc. is part of the Healthcare sector.
Vir Biotechnology, Inc. has a market cap of 1.65B USD, based on the latest quote.
Vir Biotechnology, Inc. is expected to report earnings around Nov 4, 2026. That date is an estimate and has not been confirmed by the company.
